Northwestern Mutual Investment Management Company’s Alnylam Pharmaceuticals ALNY Stock Holding History

Northwestern Mutual Investment Management Company’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-7,165	Closed	-$675K	–	912
2015 Q4	$675K	Buy	7,165 +25	+0.4%	+$2.32K	0.01%	463
2015 Q3	$574K	Hold	7,140	–	–	0.01%	502
2015 Q2	$856K	Buy	7,140 +380	+6%	+$45.4K	0.02%	438
2015 Q1	$706K	Buy	+6,760	New	+$685K	0.01%	509

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Northwestern Mutual Investment Management Company's ALNY Position: Q1 2016 in Review

Northwestern Mutual Investment Management Company sold out of Alnylam Pharmaceuticals (ALNY) in Q1 2016, closing a stake of 7,165 shares — an estimated $675K sold.

Northwestern Mutual Investment Management Company first reported a position in ALNY in Q1 2015 and held it in 4 quarters. The position peaked at $856K in Q2 2015. 255 funds tracked by Wall St. Rank hold ALNY as of Q1 2016.

Northwestern Mutual Investment Management Company reported no remaining Alnylam Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
Northwestern Mutual Investment Management Company sold 7,165 Alnylam Pharmaceuticals shares in Q1 2016, an estimated $675K.
Northwestern Mutual Investment Management Company first reported a position in Alnylam Pharmaceuticals in Q1 2015 and held it in 4 quarters.
Northwestern Mutual Investment Management Company's Alnylam Pharmaceuticals position peaked at $856K in Q2 2015.
255 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2016.

Based on Northwestern Mutual Investment Management Company's 13F filing for Q1 2016, filed 16 May 2016.